Chelsea Counsel CO Arch Therapeutics, Inc. Transaction History

Chelsea Counsel CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Feb 10, 2022	SELL	$0.06 - $0.13 $3,300 - $7,150	-55,000 Closed	0 $0
Q4 2020 Mar 08, 2022	SELL	$0.13 - $0.18 $4,394 - $6,084	-33,800 Reduced 38.06%	55,000 $8,000
Q2 2020 May 06, 2022	BUY	$0.16 - $0.23 $14,208 - $20,424	88,800 New	88,800 $14,000

Ticker ARTH
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,886,000
Market Cap $202M
Description
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...

Get notified when there are updates to the investment portfolio of Chelsea Counsel CO, based on Form 13F filings with the SEC.

Stay updated on Chelsea Counsel CO with notifications on news.